Variables | Monotherapy 39 (57.3) | Polytherapy 21 (30.9) | Without medication 8 (11.8) | P-value |
---|---|---|---|---|
n (%) | ||||
Average age ±SD (min-max) | 28.79±5.8 | 31.2±6.3 | 23.6±2.1 | 0.12 |
(17–32) | (18–35) | (21–26) | ||
Age of seizure onset | 17.8±9.1 | 15.7±6.1 | 14.1±8.1 | 0.6 |
(1–35) | (3–32) | (2–29) | ||
Disease duration (years) | 12.6±8.9 | 7.3±5.6 | 9.2±9.1 | 0.7 |
(1–35) | (3–32) | (2–29) | ||
Duration of use of AED (years) | 11.7±9.07 | 12.3±7.3 | 1.8±2.02 | 0.1 |
(0.17–31) | (0.08–24) | (0–4) | ||
Seizure semiology, n (%) | ||||
Focal seizure | 16 (41.0) | 11 (52.4) | 3 (37.5) | 0.36 |
Generalized seizure | 23 (59.0) | 10 (47.6) | 5 (62.5) | |
Number of pregnancies, n (%) | ||||
Nulliparous | 27 (69.2) | 14 (66.7) | 6 (75.0) | 0.34 |
Multiparous | 12 (30.8) | 7 (33.3) | 2 (25.0) | |
Electroencephalogram, n (%) | ||||
Normal | 15 (38.5) | 5 (23.8) | 5 (62.5) | 0.6 |
Abnormal | 24 (61.5) | 16 (76.2) | 3 (37.5) | |
Cerebral imaging (MRI), n (%) | ||||
Abnormal | 7 (17.9) | 6 (28.6) | 0 (0) | 0.5 |